Држава: Сједињене Америчке Државе
Језик: Енглески
Извор: NLM (National Library of Medicine)
RHODODENDRON AUREUM LEAF (UNII: IV92NQJ73U) (RHODODENDRON AUREUM LEAF - UNII:IV92NQJ73U)
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
ORAL
OTC DRUG
Rheumatism, Gout Condition listed above or as directed by the physician
unapproved homeopathic
RHODODENDRON CHRYSANTHUM- RHODODENDRON CHRYSANTHUM PELLET RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- ACTIVE INGREDIENT RHODODENDRON CHRYSANTHUM HPUS 3X and higher USES Rheumatism, Gout INDICATIONS Condition listed above or as directed by the physician DOSAGE Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose. WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use. INACTIVE INGREDIENTS Sucrose STORAGE Store in a cool dark place QUESTIONS OR COMMENTS www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758 RHODODENDRON CHRYSANTHUM rhododendron chrysanthum pellet PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:156 31-0 371 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH RHO DO DENDRO N AUREUM LEAF (UNII: IV9 2NQJ73U) (RHODODENDRON AUREUM LEAF - UNII:IV9 2NQJ73U) RHODODENDRON AUREUM LEAF 3 [hp_X] INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SUCRO SE (UNII: C151H8 M554) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:156 31-0 371- 0 10 0 in 1 VIAL, SINGLE-DOSE; Type 0 : No t a Co mbinatio n Pro duc t 0 1/0 1/20 18 2 NDC:156 31-0 371- 1 20 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct 0 1/0 1/20 18 3 NDC:156 31-0 371- 2 40 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct 0 1/0 1/20 Прочитајте комплетан документ